JPS6169B2 - - Google Patents

Info

Publication number
JPS6169B2
JPS6169B2 JP53078039A JP7803978A JPS6169B2 JP S6169 B2 JPS6169 B2 JP S6169B2 JP 53078039 A JP53078039 A JP 53078039A JP 7803978 A JP7803978 A JP 7803978A JP S6169 B2 JPS6169 B2 JP S6169B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP53078039A
Other versions
JPS557014A (en
Inventor
Yutaka Sugawara
Akihiro Yamamoto
Mitsuaki Handa
Hiroko Usami
Haruki Ogawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to JP7803978A priority Critical patent/JPS557014A/ja
Priority to GB7920677A priority patent/GB2025768B/en
Priority to US06/049,744 priority patent/US4242326A/en
Priority to IT68342/79A priority patent/IT1119922B/it
Priority to CA000330751A priority patent/CA1135640A/en
Priority to FR7916586A priority patent/FR2429594A1/fr
Priority to SE7905703A priority patent/SE449439B/sv
Priority to CS794488A priority patent/CS235079B2/cs
Priority to DE19792926406 priority patent/DE2926406A1/de
Priority to CH611479A priority patent/CH641354A5/de
Publication of JPS557014A publication Critical patent/JPS557014A/ja
Publication of JPS6169B2 publication Critical patent/JPS6169B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46Streptococcus ; Enterococcus; Lactococcus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/885Streptococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP7803978A 1978-06-29 1978-06-29 Antitumor agent and its preparation Granted JPS557014A (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP7803978A JPS557014A (en) 1978-06-29 1978-06-29 Antitumor agent and its preparation
GB7920677A GB2025768B (en) 1978-06-29 1979-06-14 Antitumour substance from hemolytic streptococci
US06/049,744 US4242326A (en) 1978-06-29 1979-06-18 Anti-tumor substance and process for preparing the same
IT68342/79A IT1119922B (it) 1978-06-29 1979-06-22 Sostanza anti tumorale e procedimento per la sua preparazione
CA000330751A CA1135640A (en) 1978-06-29 1979-06-26 Anti-tumor substance and process for preparing the same
FR7916586A FR2429594A1 (fr) 1978-06-29 1979-06-27 Substance anti-tumorale, son procede de preparation et son application en therapeutique
SE7905703A SE449439B (sv) 1978-06-29 1979-06-28 Forfarande for framstellning av en antitumorsubstans ur hemolytiska streptokocker
CS794488A CS235079B2 (en) 1978-06-29 1979-06-28 Method of antitumour substance preparation
DE19792926406 DE2926406A1 (de) 1978-06-29 1979-06-29 Praeparat zur behandlung maligner neoplasien und verfahren zu seiner herstellung
CH611479A CH641354A5 (de) 1978-06-29 1979-06-29 Material mit antitumorwirkung und verfahren zu dessen herstellung.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7803978A JPS557014A (en) 1978-06-29 1978-06-29 Antitumor agent and its preparation

Publications (2)

Publication Number Publication Date
JPS557014A JPS557014A (en) 1980-01-18
JPS6169B2 true JPS6169B2 (ja) 1986-01-06

Family

ID=13650677

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7803978A Granted JPS557014A (en) 1978-06-29 1978-06-29 Antitumor agent and its preparation

Country Status (10)

Country Link
US (1) US4242326A (ja)
JP (1) JPS557014A (ja)
CA (1) CA1135640A (ja)
CH (1) CH641354A5 (ja)
CS (1) CS235079B2 (ja)
DE (1) DE2926406A1 (ja)
FR (1) FR2429594A1 (ja)
GB (1) GB2025768B (ja)
IT (1) IT1119922B (ja)
SE (1) SE449439B (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4479935A (en) * 1980-04-22 1984-10-30 Institut Pasteur Fractions extracted from aerobic bacteria, endowed with antitumoral, antibacterial and interferon inducing properties, and process for their preparation
JPS58222026A (ja) * 1982-06-18 1983-12-23 Masahiro Yoshimura 抗ガン性物質
JPS6169725A (ja) * 1984-09-13 1986-04-10 Juzo Udaka 抗腫瘍性物質spf−140及びその製法
US4978622A (en) * 1986-06-23 1990-12-18 Regents Of The University Of California Cytophaga-derived immunopotentiator
US5010062A (en) * 1989-09-25 1991-04-23 Vanderbilt University Therapeutic agent and method of inhibiting vascularization of tumors
ES2027518A6 (es) * 1990-12-18 1992-06-01 Andromaco Lab Procedimiento para la preparacion de nuevas asociaciones no covalentes polisacarido-proteina con actividad farmacologica.
US5811403A (en) 1996-09-30 1998-09-22 Vanderbilt University Polysaccharide toxin from Group B β-hemolytic Streptococcus (GBS) having improved purity
JPH10139670A (ja) * 1996-11-11 1998-05-26 Terukuni Yakida インターロイキン12誘導物質及び医薬組成物
US6670337B1 (en) * 1998-01-29 2003-12-30 Yeda Reaearch And Development Co., Ltd. Facilitation of wound healing with CM101/GBS toxin
US5858991A (en) * 1997-01-29 1999-01-12 Vanderbilt University Facilitation of wound healing with CM101/GBS toxin
US5981508A (en) * 1997-01-29 1999-11-09 Vanderbilt University Facilitation of repair of neural injury with CM101/GBS toxin
US6028060A (en) 1997-01-29 2000-02-22 Vanderbilt University Treatment of chronic inflammatory diseases with CM101/GBS toxin
US8609614B2 (en) * 1998-07-22 2013-12-17 Vanderbilt University GBS toxin receptor compositions and methods of use
US6803448B1 (en) 1998-07-22 2004-10-12 Vanderbilt University GBS toxin receptor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1132676A (en) * 1966-03-08 1968-11-06 Chugai Pharmaceutical Co Ltd Anti-tumour preparation and process for preparing the same
GB1153113A (en) * 1967-01-20 1969-05-21 Chugai Pharmaceutical Co Ltd Method of Treating Hemolytic Streptococci and the Resultant Preparation containing the same
GB1163865A (en) * 1967-02-01 1969-09-10 Kyowa Hakko Kogyo Kk Process for the preparation of Anti-Tumor Substances
US3632746A (en) * 1967-08-30 1972-01-04 Chugai Pharmaceutical Co Ltd Dried stable anti-tumor preparations and process for preparing the same
JPS4843841B1 (ja) * 1969-09-06 1973-12-21
JPS496096B1 (ja) * 1970-09-30 1974-02-12
JPS50160419A (ja) * 1974-05-08 1975-12-25

Also Published As

Publication number Publication date
FR2429594B1 (ja) 1983-04-01
CA1135640A (en) 1982-11-16
IT1119922B (it) 1986-03-19
SE7905703L (sv) 1979-12-30
GB2025768A (en) 1980-01-30
FR2429594A1 (fr) 1980-01-25
IT7968342A0 (it) 1979-06-22
US4242326A (en) 1980-12-30
DE2926406A1 (de) 1980-01-10
CH641354A5 (de) 1984-02-29
CS235079B2 (en) 1985-04-16
JPS557014A (en) 1980-01-18
SE449439B (sv) 1987-05-04
GB2025768B (en) 1982-11-24

Similar Documents

Publication Publication Date Title
FR2429594B1 (ja)
FR2415601B1 (ja)
DE2802180C2 (ja)
FR2413670B1 (ja)
BG25957A1 (ja)
BG25835A1 (ja)
CH617307GA3 (ja)
BG25954A1 (ja)
BG26238A1 (ja)
BG26022A1 (ja)
BG26017A1 (ja)
BG26015A1 (ja)
BG26014A1 (ja)
BG26013A1 (ja)
BG26012A1 (ja)
BG26009A1 (ja)
BG26008A1 (ja)
BG26007A1 (ja)
BG26006A1 (ja)
BG25974A1 (ja)
BG25973A1 (ja)
BG25940A1 (ja)
BG25971A1 (ja)
BG25889A1 (ja)
BG25956A1 (ja)